Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Test Procedure Diagnoses Multi-Resistant Pathogens

By LabMedica International staff writers
Posted on 01 Oct 2018
Patients with bloodstream infections caused by gram-negative pathogens such as Escherichia coli (E. More...
coli) have a high mortality rate. However, the infection has so far usually been treatable with antibiotics.

Due to the increased antibiotic resistance of bacteria, also against the group of carbapenems, therapy has become increasingly difficult. Infections with multi-resistant pathogens that are also resistant to such 'reserve antibiotics' often lead to ineffective antibiotic therapy and thus to higher mortality.

Medical microbiologists at the University Hospital of Cologne (Cologne, Germany) and their partners analyzed in a study, a total of 126 Enterobacteriaceae clinical isolates harboring different carbapenemases and 44 Enterobacteriaceae clinical isolates that were carbapenemase-negative. Klebsiella pneumoniae was the most frequent species (N = 84), followed by Escherichia coli (N = 53) and Enterobacter cloacae (N = 15). Carbapenemase-producing isolates (CPE) included the three carbapenemases: 79 carbapenem-hydrolysing class D β-lactamases (OXA-48-like), 29 New Delhi metallo-betalactamase (NDM) or 18 Klebsiella pneumoniae carbapenemase (KPC).

The team developed and evaluated a new method for the rapid detection of carbapenemases directly from positive blood culture (BC) using a new multiplex immunochromatographic test (ICT). After spiking with bacteria and incubation in a BC system, blood from positive BC bottles was hemolyzed, and bacteria concentrated by centrifugation and lysed. The lysate was transferred to the RESIST-3 O.K.N. ICT, which detects OXA-48-like, KPC and NDM carbapenemases.

The final results of the immunochromatography test (ICT) were read when they became positive, at the latest after 15 minutes. All CPE isolates (126/126) were correctly detected with the new protocol (100% sensitivity, 100% specificity). There was perfect concordance between ICT results and molecular characterization and total time to result was 20 to 45 minutes. Three of the four most common carbapenemases, OXA-48, KPC and NDM, were discovered directly from positive blood cultures using a single test procedure without the need for time-consuming further cultivation on agar plates. The new method is fast, easy to use, inexpensive, approximately EUR 10/test and can be performed in any clinical microbiology laboratory.

Axel Hamprecht, MD, a professor and lead author of the study said, “With this procedure, we have come a giant step closer to our goal of being able to help patients infected with multi-resistant pathogens as quickly as possible. In the case of the aggressive pathogens we are confronted with, every minute counts in order to start a targeted therapy.” The study was published on September 14, 2018, in the journal PLOS ONE.

Related Links:
University Hospital of Cologne


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.